Showing results (211-220 of 236) with videos related to
Sort By:
Pageof 24
Journal of the American College of Nutrition|July 24, 2020
MUST-Plus: A Machine Learning Classifier That Improves Malnutrition Screening in Acute Care FacilitiesPrem Timsina, Himanshu N Joshi, Fu-Yuan Cheng, et al.Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
LLM-Guided Pain Management: Examining Socio-Demographic Gaps in Cancer vs non-Cancer casesMahmud Omar, Shelly Soffer, Reem Agbareia, et al.Health Care Management Science|November 8, 2020
Developing an Institute for Health Care Delivery Science: successes, challenges, and solutions in the first five yearsMadhu Mazumdar, Jashvant V Poeran, Bart S Ferket, et al.Bone Marrow Transplantation|January 5, 2016
Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis studyS Afifi, N G Adel, S Devlin, et al.Bioengineering (Basel, Switzerland)|June 27, 2024
Development and Validation of a Deep Learning Classifier Using Chest Radiographs to Predict Extubation Success in Patients Undergoing Invasive Mechanical VentilationPranai Tandon, Kim-Anh-Nhi Nguyen, Masoud Edalati, et al.JAMA Network Open|May 7, 2025
Machine Learning Multimodal Model for Delirium Risk StratificationJoseph I Friedman, Prathamesh Parchure, Fu-Yuan Cheng, et al.Plos One|September 17, 2015
DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S. cerevisiaeLindsey A Bierle, Kira L Reich, Braden E Taylor, et al.Journal of Clinical Medicine|February 5, 2020
MEWS++: Enhancing the Prediction of Clinical Deterioration in Admitted Patients through a Machine Learning ModelArash Kia, Prem Timsina, Himanshu N Joshi, et al.Blood|November 1, 1982
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone)S Kempin, B J Lee, H T Thaler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancerC Aghajanian, D Fennelly, F Shapiro, et al.Pageof 24